Table 2.
Further characterization |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Discovery |
Replication Early sPTBb |
Late sPTBc |
mPTBd |
||||||||||
Namea | CHR | Position | Gene | Location | Annotation | βdiffe | P | βdiff | P | βdiff | P | βdiff | P |
cg13264543 | 6 | 7730937 | BMP6 | Body | CDMR | −4.4 | 2.0 × 10−6 | −1.0 | 0.58 | 1.6 | 0.15 | 1.4 | 0.28 |
cg03915055 | 2 | 158301005 | CYTIP | TSS1500 | −4.1 | 1.1 × 10−13 | −2.7 | 0.03 | −0.9 | 0.04 | −3.3 | 4.3 × 10−7 | |
cg06804705 | 21 | 40125580 | LINC00114 | TSS1500 | −3.4 | 6.5 × 10−7 | −4.6 | 0.002 | −1.1 | 0.06 | −4.2 | 0.001 | |
cg14195992 | 8 | 48265917 | KIAA0146 | Body | Enhancer, DHS | −2.7 | 2.0 × 10−6 | 0.2 | 0.23 | 1.6 | 0.09 | 0.4 | 0.51 |
cg24892948 | 19 | 36001897 | DMKN | TSS1500 | 2.6 | 4.2 × 10−6 | −4.0 | 0.02 | −1.5 | 0.10 | −1.0 | 0.25 | |
cg03445220 | 1 | 244747323 | C1orf101 | Body | 2.4 | 5.1 × 10−6 | 0.1 | 0.65 | 0.3 | 0.45 | −0.6 | 0.57 | |
cg11936089 | 11 | 64270294 | NA | NA | Island | 2.4 | 1.7 × 10−6 | 1.0 | 0.36 | −1.5 | 0.10 | −0.9 | 0.56 |
cg19226017 | 6 | 35697185 | FKBP5 | TSS1500 | −2.2 | 1.1 × 10−6 | −0.2 | 0.33 | −0.1 | 0.67 | −1.7 | 0.04 | |
cg16187013 | 10 | 133949209 | JAKMIP3 | Body | Island | 2.1 | 6.3 × 10−7 | −2.2 | 0.11 | −0.7 | 0.57 | −1.0 | 0.65 |
CDMR: cancer-specific differentially methylation regions; DHS: DNase I hypersensitive sites; PTB: preterm birth; mPTB: medically-indicated PTB; sPTB: spontaneous PTB at <37 weeks of gestation; early sPTB: spontaneous PTB at 24- 336/7 weeks of gestation. NA: not applicable. FDR: False discovery rate.
The table shows the top 9 FDR-significant loci with absolute DNA methylation changes >2% between mothers with early sPTBs and mothers with TBs in the discovery sample, which were sorted by this absolute methylation change.
b,c,dIn the replication and further characterization stage, b indicates 7 mothers with early sPTBs, c indicates 34 mothers with late PTBs and d indicates 14 mothers with early medically-indicated PTBs as the PTB cases compared to 54 TB controls.
βdiff reflects the DNA methylation changes (%) between mothers with PTBs (cases) and mothers with TBs (controls). The βdiff <0 means that the methylation level was lower in cases than in controls, while βdiff > 0 means the methylation level was higher in cases than in controls.